The global Peptide Synthesis Service market size was valued at USD 1021.7 million in 2023 and is forecast to a readjusted size of USD 1659.9 million by 2030 with a CAGR of 7.2% during review period.
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report includes an overview of the development of the Peptide Synthesis Service industry chain, the market status of Commercial (CRO Peptides, CMO Peptides), Academic Research (CRO Peptides, CMO Peptides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peptide Synthesis Service.
Regionally, the report analyzes the Peptide Synthesis Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peptide Synthesis Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Peptide Synthesis Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peptide Synthesis Service industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CRO Peptides, CMO Peptides).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peptide Synthesis Service market.
Regional Analysis: The report involves examining the Peptide Synthesis Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peptide Synthesis Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Peptide Synthesis Service:
Company Analysis: Report covers individual Peptide Synthesis Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peptide Synthesis Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Commercial, Academic Research).
Technology Analysis: Report covers specific technologies relevant to Peptide Synthesis Service. It assesses the current state, advancements, and potential future developments in Peptide Synthesis Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peptide Synthesis Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Peptide Synthesis Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
麻豆原创 segment by Application
Commercial
Academic Research
麻豆原创 segment by players, this report covers
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Peptide Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide Synthesis Service, with revenue, gross margin and global market share of Peptide Synthesis Service from 2019 to 2024.
Chapter 3, the Peptide Synthesis Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Peptide Synthesis Service market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide Synthesis Service.
Chapter 13, to describe Peptide Synthesis Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Peptide Synthesis Service
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Peptide Synthesis Service by Type
1.3.1 Overview: Global Peptide Synthesis Service 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Peptide Synthesis Service Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 CRO Peptides
1.3.4 CMO Peptides
1.3.5 Generic API Peptides
1.4 Global Peptide Synthesis Service 麻豆原创 by Application
1.4.1 Overview: Global Peptide Synthesis Service 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Commercial
1.4.3 Academic Research
1.5 Global Peptide Synthesis Service 麻豆原创 Size & Forecast
1.6 Global Peptide Synthesis Service 麻豆原创 Size and Forecast by Region
1.6.1 Global Peptide Synthesis Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Peptide Synthesis Service 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Peptide Synthesis Service 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Peptide Synthesis Service 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Peptide Synthesis Service 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Peptide Synthesis Service 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Peptide Synthesis Service 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Bachem
2.1.1 Bachem Details
2.1.2 Bachem Major Business
2.1.3 Bachem Peptide Synthesis Service Product and Solutions
2.1.4 Bachem Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Bachem Recent Developments and Future Plans
2.2 PolyPeptide
2.2.1 PolyPeptide Details
2.2.2 PolyPeptide Major Business
2.2.3 PolyPeptide Peptide Synthesis Service Product and Solutions
2.2.4 PolyPeptide Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 PolyPeptide Recent Developments and Future Plans
2.3 GL Biochem
2.3.1 GL Biochem Details
2.3.2 GL Biochem Major Business
2.3.3 GL Biochem Peptide Synthesis Service Product and Solutions
2.3.4 GL Biochem Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GL Biochem Recent Developments and Future Plans
2.4 Xinbang
2.4.1 Xinbang Details
2.4.2 Xinbang Major Business
2.4.3 Xinbang Peptide Synthesis Service Product and Solutions
2.4.4 Xinbang Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Xinbang Recent Developments and Future Plans
2.5 Hybio
2.5.1 Hybio Details
2.5.2 Hybio Major Business
2.5.3 Hybio Peptide Synthesis Service Product and Solutions
2.5.4 Hybio Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Hybio Recent Developments and Future Plans
2.6 USVPeptides
2.6.1 USVPeptides Details
2.6.2 USVPeptides Major Business
2.6.3 USVPeptides Peptide Synthesis Service Product and Solutions
2.6.4 USVPeptides Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 USVPeptides Recent Developments and Future Plans
2.7 Thermofischer
2.7.1 Thermofischer Details
2.7.2 Thermofischer Major Business
2.7.3 Thermofischer Peptide Synthesis Service Product and Solutions
2.7.4 Thermofischer Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Thermofischer Recent Developments and Future Plans
2.8 ScinoPharm
2.8.1 ScinoPharm Details
2.8.2 ScinoPharm Major Business
2.8.3 ScinoPharm Peptide Synthesis Service Product and Solutions
2.8.4 ScinoPharm Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 ScinoPharm Recent Developments and Future Plans
2.9 Genscript
2.9.1 Genscript Details
2.9.2 Genscript Major Business
2.9.3 Genscript Peptide Synthesis Service Product and Solutions
2.9.4 Genscript Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Genscript Recent Developments and Future Plans
2.10 AnaSpec
2.10.1 AnaSpec Details
2.10.2 AnaSpec Major Business
2.10.3 AnaSpec Peptide Synthesis Service Product and Solutions
2.10.4 AnaSpec Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 AnaSpec Recent Developments and Future Plans
2.11 New England Peptide
2.11.1 New England Peptide Details
2.11.2 New England Peptide Major Business
2.11.3 New England Peptide Peptide Synthesis Service Product and Solutions
2.11.4 New England Peptide Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 New England Peptide Recent Developments and Future Plans
2.12 CPC Scientific
2.12.1 CPC Scientific Details
2.12.2 CPC Scientific Major Business
2.12.3 CPC Scientific Peptide Synthesis Service Product and Solutions
2.12.4 CPC Scientific Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 CPC Scientific Recent Developments and Future Plans
2.13 JPT
2.13.1 JPT Details
2.13.2 JPT Major Business
2.13.3 JPT Peptide Synthesis Service Product and Solutions
2.13.4 JPT Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 JPT Recent Developments and Future Plans
2.14 21st Century Bio
2.14.1 21st Century Bio Details
2.14.2 21st Century Bio Major Business
2.14.3 21st Century Bio Peptide Synthesis Service Product and Solutions
2.14.4 21st Century Bio Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 21st Century Bio Recent Developments and Future Plans
2.15 LifeTein
2.15.1 LifeTein Details
2.15.2 LifeTein Major Business
2.15.3 LifeTein Peptide Synthesis Service Product and Solutions
2.15.4 LifeTein Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 LifeTein Recent Developments and Future Plans
2.16 Proimmune
2.16.1 Proimmune Details
2.16.2 Proimmune Major Business
2.16.3 Proimmune Peptide Synthesis Service Product and Solutions
2.16.4 Proimmune Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Proimmune Recent Developments and Future Plans
2.17 Biomatik
2.17.1 Biomatik Details
2.17.2 Biomatik Major Business
2.17.3 Biomatik Peptide Synthesis Service Product and Solutions
2.17.4 Biomatik Peptide Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Biomatik Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Peptide Synthesis Service Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Peptide Synthesis Service by Company Revenue
3.2.2 Top 3 Peptide Synthesis Service Players 麻豆原创 Share in 2023
3.2.3 Top 6 Peptide Synthesis Service Players 麻豆原创 Share in 2023
3.3 Peptide Synthesis Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 Peptide Synthesis Service 麻豆原创: Region Footprint
3.3.2 Peptide Synthesis Service 麻豆原创: Company Product Type Footprint
3.3.3 Peptide Synthesis Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Peptide Synthesis Service Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Peptide Synthesis Service 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Peptide Synthesis Service Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Peptide Synthesis Service 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Peptide Synthesis Service Consumption Value by Type (2019-2030)
6.2 North America Peptide Synthesis Service Consumption Value by Application (2019-2030)
6.3 North America Peptide Synthesis Service 麻豆原创 Size by Country
6.3.1 North America Peptide Synthesis Service Consumption Value by Country (2019-2030)
6.3.2 United States Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Peptide Synthesis Service Consumption Value by Type (2019-2030)
7.2 Europe Peptide Synthesis Service Consumption Value by Application (2019-2030)
7.3 Europe Peptide Synthesis Service 麻豆原创 Size by Country
7.3.1 Europe Peptide Synthesis Service Consumption Value by Country (2019-2030)
7.3.2 Germany Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Peptide Synthesis Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Peptide Synthesis Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Peptide Synthesis Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific Peptide Synthesis Service Consumption Value by Region (2019-2030)
8.3.2 China Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Peptide Synthesis Service Consumption Value by Type (2019-2030)
9.2 South America Peptide Synthesis Service Consumption Value by Application (2019-2030)
9.3 South America Peptide Synthesis Service 麻豆原创 Size by Country
9.3.1 South America Peptide Synthesis Service Consumption Value by Country (2019-2030)
9.3.2 Brazil Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Peptide Synthesis Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Peptide Synthesis Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Peptide Synthesis Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa Peptide Synthesis Service Consumption Value by Country (2019-2030)
10.3.2 Turkey Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Peptide Synthesis Service 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Peptide Synthesis Service 麻豆原创 Drivers
11.2 Peptide Synthesis Service 麻豆原创 Restraints
11.3 Peptide Synthesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Peptide Synthesis Service Industry Chain
12.2 Peptide Synthesis Service Upstream Analysis
12.3 Peptide Synthesis Service Midstream Analysis
12.4 Peptide Synthesis Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
听
听
*If Applicable.
